Contraline
Long-acting reversible male contraceptive
About
Contraline develops ADAM, the first long-acting, reversible non-hormonal male contraceptive using a hydrogel technology. Spun out of UVA biomedical engineering. Raised $24M+.
Discussion (0)
Sign in to leave a comment.
No comments yet. Be the first to share your thoughts!